First American Gastroenterological Association living guideline for moderate-to-severe ulcerative colitis Dr. Kamal Kant Kohli26 Nov 2024 8:15 PM ISTThe American Gastroenterological Association (AGA) has released a new clinical guideline on the pharmacological management of moderate-to-severe...
Ulcerative colitis causally related to male infertility, claims research Dr. Shravani Dali17 Nov 2024 8:45 PM ISTUlcerative colitis causally related to male infertility, claims research published in the PLOS ONE.A study was done to explore the causal...
Researchers develop probiotic to ameliorate ulcerative colitis Dr. Kamal Kant Kohli14 Nov 2024 8:00 PM ISTResearchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences have developed a probiotic-based therapeutic that...
NEJM: Results from targeted therapy for ulcerative colitis study Dr. Kamal Kant Kohli30 Sept 2024 2:00 AM ISTAn international placebo-controlled study led by Cedars-Sinai suggests that a targeted drug therapy that was developed by researchers at Cedars-Sinai...
JnJ Tremfya receives USFDA approval for adults with moderately to severely active ulcerative colitis Ruchika Sharma12 Sept 2024 12:30 PM ISTHorsham: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved TREMFYA (guselkumab) for the treatment of...
Biocon Biologics secures market entry for Bmab 1200 in Europe, UK, Canada, Japan Ruchika Sharma29 Aug 2024 12:30 PM ISTBangalore: Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and a subsidiary of Biocon Ltd, announced today that the...
Intas Pharmaceuticals Gets CDSCO Panel Nod to Study Vedolizumab for Ulcerative Colitis Dr. Divya Colin13 Aug 2024 6:00 PM ISTNew Delhi: Intas Pharmaceuticals has got the go-ahead from the Subject Expert Committee ( SEC) functional under the Central Drug Standard Control...
Risankizumab improves clinical remission rates of moderate to high active ulcerative colitis, finds research Jacinthlyn Sylvia26 July 2024 9:00 PM ISTA recent research published in the Journal of American Medical Association found that risankizumab improved clinical remission rates in an induction...
Coconut water more effective than placebo for inducing clinical remission in patients with mild to moderate ulcerative colitis: Study Dr. Shravani Dali24 Jun 2024 9:00 AM ISTCoconut water is more effective than a placebo for inducing clinical remission in patients with mild to moderate ulcerative colitis suggests a study...
JnJ seeks USFDA approval for Tremfya for moderately to severely active Crohn's disease Ruchika Sharma22 Jun 2024 2:21 PM ISTSpring House: Johnson & Johnson has announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug...
JnJ submits regulatory applications to EMA for Tremfya for treatment of patients with ulcerative colitis, Crohn's disease Ruchika Sharma5 May 2024 1:30 PM ISTBeerse: Janssen-Cilag International NV, a Johnson & Johnson company, has announced it has submitted applications to the European Medicines...
New Study Reveals Comparable Postoperative Risks of Tofacitinib and Biologics in Ulcerative Colitis Patients Dr.Niharika Harsha B15 April 2024 6:45 AM ISTIn a significant breakthrough, a recent multicenter retrospective study has shed light on the postoperative outcomes of ulcerative colitis (UC)...
